The Relationship Between Dietary Patterns and Glycemic Variability in People with Impaired Glucose Tolerance.


Journal

The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243

Informations de publication

Date de publication:
05 2023
Historique:
received: 16 10 2022
revised: 03 03 2023
accepted: 07 03 2023
pmc-release: 10 03 2024
medline: 8 5 2023
pubmed: 12 3 2023
entrez: 11 3 2023
Statut: ppublish

Résumé

Diurnal glucose fluctuations are increased in prediabetes and might be affected by specific dietary patterns. The present study assessed the relationship between glycemic variability (GV) and dietary regimen in people with normal glucose tolerance (NGT) and impaired glucose tolerance (IGT). Forty-one NGT (mean age: 45.0 ± 9.0 y, mean BMI: 32.0 ± 7.0 kg/m Despite no difference in diet patterns between the 2 groups, GV parameters were higher in IGT than in NGT. GV worsened with an increase in overall daily carbohydrate and refined grain consumption and improved with the increase in whole grain intake in IGT. GV parameters were positively related [r = 0.14-0.53; all P < 0.02 for SD, continuous overall net glycemic action 1 (CONGA1), J-index, lability index (LI), glycemic risk assessment diabetes equation, M-value, and mean absolute glucose (MAG)], and low blood glucose index (LBGI) inversely (r = -0.37, P = 0.006) related to the total percentage of carbohydrate, but not to the distribution of carbohydrate between the main meals in the IGT group. A negative relationship existed between total protein consumption and GV indices (r = -0.27 to -0.52; P < 0.05 for SD, CONGA1, J-index, LI, M-value, and MAG). The total EI was related to GV parameters (r = 0.27-0.32; P < 0.05 for CONGA1, J-index, LI, and M-value; and r = -0.30, P = 0.028 for LBGI). The primary outcome results showed that insulin sensitivity, calories, and carbohydrate content are predictors of GV in individuals with IGT. Overall, the secondary analyses suggested that carbohydrate and daily consumption of refined grains might be associated with higher GV, whereas whole grains and daily protein intake were related to lower GV in people with IGT.

Sections du résumé

BACKGROUND
Diurnal glucose fluctuations are increased in prediabetes and might be affected by specific dietary patterns.
OBJECTIVES
The present study assessed the relationship between glycemic variability (GV) and dietary regimen in people with normal glucose tolerance (NGT) and impaired glucose tolerance (IGT).
METHODS
Forty-one NGT (mean age: 45.0 ± 9.0 y, mean BMI: 32.0 ± 7.0 kg/m
RESULTS
Despite no difference in diet patterns between the 2 groups, GV parameters were higher in IGT than in NGT. GV worsened with an increase in overall daily carbohydrate and refined grain consumption and improved with the increase in whole grain intake in IGT. GV parameters were positively related [r = 0.14-0.53; all P < 0.02 for SD, continuous overall net glycemic action 1 (CONGA1), J-index, lability index (LI), glycemic risk assessment diabetes equation, M-value, and mean absolute glucose (MAG)], and low blood glucose index (LBGI) inversely (r = -0.37, P = 0.006) related to the total percentage of carbohydrate, but not to the distribution of carbohydrate between the main meals in the IGT group. A negative relationship existed between total protein consumption and GV indices (r = -0.27 to -0.52; P < 0.05 for SD, CONGA1, J-index, LI, M-value, and MAG). The total EI was related to GV parameters (r = 0.27-0.32; P < 0.05 for CONGA1, J-index, LI, and M-value; and r = -0.30, P = 0.028 for LBGI).
CONCLUSIONS
The primary outcome results showed that insulin sensitivity, calories, and carbohydrate content are predictors of GV in individuals with IGT. Overall, the secondary analyses suggested that carbohydrate and daily consumption of refined grains might be associated with higher GV, whereas whole grains and daily protein intake were related to lower GV in people with IGT.

Identifiants

pubmed: 36906149
pii: S0022-3166(23)35424-5
doi: 10.1016/j.tjnut.2023.03.007
pmc: PMC10196612
pii:
doi:

Substances chimiques

Blood Glucose 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1427-1438

Informations de copyright

Copyright © 2023 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.

Références

BMJ Open Diabetes Res Care. 2020 Jul;8(1):
pubmed: 32718934
Diabetes Care. 2009 Sep;32(9):1600-2
pubmed: 19542012
Diabetes. 1970 Sep;19(9):644-55
pubmed: 5469118
J Clin Res Pediatr Endocrinol. 2017 Sep 1;9(3):202-207
pubmed: 28163257
Diabetes Obes Metab. 2017 Oct;19(10):1479-1484
pubmed: 28345762
Diabetes. 2004 Apr;53(4):955-62
pubmed: 15047610
Nutr J. 2017 Jul 12;16(1):43
pubmed: 28701162
Diabetes Ther. 2019 Dec;10(6):2289-2304
pubmed: 31659627
Acta Med Scand. 1965 Jan;177:95-102
pubmed: 14251860
Diabetes Obes Metab. 2019 Feb;21(2):377-381
pubmed: 30101510
Diabetologia. 2014 Sep;57(9):1807-11
pubmed: 25005331
Nutrients. 2019 Dec 16;11(12):
pubmed: 31888175
Horm Metab Res. 1995 Jan;27(1):41-2
pubmed: 7729793
Diabetes Care. 2013 Dec;36(12):4057-62
pubmed: 24170753
Diabetes Res Clin Pract. 2013 Nov;102(2):86-95
pubmed: 24128999
Diabetes Res Clin Pract. 2019 May;151:56-64
pubmed: 30935927
Diabet Med. 2007 Jul;24(7):753-8
pubmed: 17459094
Endocrinol Diabetes Metab Case Rep. 2018 Mar 21;2018:
pubmed: 29576869
Diabetes Technol Ther. 2005 Apr;7(2):253-63
pubmed: 15857227
Nutr Diabetes. 2016 Aug 22;6(8):e226
pubmed: 27548711
Br J Nutr. 2019 Mar 14;121(5):560-566
pubmed: 30526707
Am J Clin Nutr. 2019 May 1;109(5):1302-1309
pubmed: 30968140
J Clin Med. 2020 Oct 13;9(10):
pubmed: 33066307
Diabetes Res Clin Pract. 2019 Sep;155:107818
pubmed: 31425769
J Diabetes Sci Technol. 2014 Mar 2;8(2):286-290
pubmed: 24876580
Diabetes Res Clin Pract. 2019 Dec;158:107911
pubmed: 31707004
Diabetes Care. 2015 Apr;38(4):682-8
pubmed: 25573884
Diabetes. 2009 Apr;58(4):773-95
pubmed: 19336687
J Clin Invest. 1991 Feb;87(2):415-23
pubmed: 1991827
Int J Environ Res Public Health. 2021 Sep 03;18(17):
pubmed: 34501920
Diabetes Technol Ther. 2013 Sep;15(9):762-7
pubmed: 23931715
Am J Med Sci. 2018 Dec;356(6):518-527
pubmed: 30447705
Clin Chim Acta. 2016 Oct 1;461:146-50
pubmed: 27502250
Am J Physiol Regul Integr Comp Physiol. 2014 Feb 1;306(3):R157-63
pubmed: 24352410
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28
pubmed: 30559228
Nutrients. 2017 May 09;9(5):
pubmed: 28486426
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Diabetes Technol Ther. 2003;5(5):817-28
pubmed: 14633347
Crit Care Med. 2010 Mar;38(3):838-42
pubmed: 20035218
Clin Nutr ESPEN. 2020 Oct;39:46-52
pubmed: 32859328
BMC Nutr. 2019 Feb 20;5:15
pubmed: 32153928
Eur J Nutr. 2020 Aug;59(5):1929-1936
pubmed: 31292751
Eur J Clin Nutr. 2006 Sep;60(9):1122-9
pubmed: 16670695

Auteurs

Rumyana Dimova (R)

Department of Endocrinology, Medical University Sofia, Sofia, Bulgaria. Electronic address: dr.roumyana.dimova@gmail.com.

Nevena Chakarova (N)

Department of Endocrinology, Medical University Sofia, Sofia, Bulgaria.

Stefano Del Prato (S)

Department of Clinical and Experimental Medicine, University of Pisa, Via Pietro Trivella, Italy.

Tsvetalina Tankova (T)

Department of Endocrinology, Medical University Sofia, Sofia, Bulgaria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH